Related Experiment Video
Updated: Jun 18, 2025

Author Spotlight: Developing Immunocompetent Organ-on-Chip Models for Infectious Disease Research
Published on: May 24, 2024
Phage-Mediated Digestive Decolonization in a Gut-On-A-Chip Model: A Tale of Gut-Specific Bacterial Prosperity
Brieuc Van Nieuwenhuyse1, Maya Merabishvili2, Nathalie Goeders3
1Institute of Experimental and Clinical Research, Pediatric Department (IREC/PEDI), Université Catholique de Louvain-UCLouvain, 1200 Brussels, Belgium.
Abstract:
Infections due to antimicrobial-resistant bacteria have become a major threat to global health. Some patients may carry resistant bacteria in their gut microbiota. Specific risk factors may trigger the conversion of these carriages into infections in hospitalized patients. Preventively eradicating these carriages has been postulated as a promising preventive intervention. However, previous attempts at such eradication using oral antibiotics or probiotics have led to discouraging results. Phage therapy, the therapeutic use of bacteriophage viruses, might represent a worthy alternative in this context. Taking inspiration from this clinical challenge, we built Gut-On-A-Chip (GOAC) models, which are tridimensional cell culture models mimicking a simplified gut section. These were used to better understand bacterial dynamics under phage pressure using two relevant species: Pseudomonas aeruginosa and Escherichia coli. Model mucus secretion was documented by ELISA assays. Bacterial dynamics assays were performed in GOAC triplicates monitored for 72 h under numerous conditions, such as pre-, per-, or post-bacterial timing of phage introduction, punctual versus continuous phage administration, and phage expression of mucus-binding properties. The potential genomic basis of bacterial phage resistance acquired in the model was investigated by variant sequencing. The bacterial "escape growth" rates under phage pressure were compared to static in vitro conditions. Our results suggest that there is specific bacterial prosperity in this model compared to other in vitro conditions. In E. coli assays, the introduction of a phage harboring unique mucus-binding properties could not shift this balance of power, contradicting previous findings in an in vivo mouse model and highlighting the key differences between these models. Genomic modifications were correlated with bacterial phage resistance acquisition in some but not all instances, suggesting that alternate ways are needed to evade phage predation, which warrants further investigation.
Insights
Phage therapy shows potential for combating antimicrobial-resistant bacteria in the gut. Gut-On-A-Chip models revealed complex bacterial dynamics and resistance mechanisms, suggesting new avenues for treatment.
Area of Science:
- Microbiology
- Bioengineering
- Infectious Diseases
Background:
- Antimicrobial resistance poses a global health threat.
- Gut microbiota carriage of resistant bacteria can lead to infections.
- Previous eradication strategies have yielded limited success.
Purpose of the Study:
- To investigate phage therapy's potential against gut resistant bacteria.
- To model bacterial dynamics under phage pressure using Gut-On-A-Chip (GOAC).
- To explore phage resistance mechanisms and bacterial adaptation.
Main Methods:
- Developed and utilized Gut-On-A-Chip (GOAC) models.
- Assessed bacterial dynamics of *Pseudomonas aeruginosa* and *Escherichia coli* under phage pressure.
- Analyzed phage administration timing, duration, and mucus-binding properties.
- Investigated genomic basis of phage resistance via variant sequencing.
Main Results:
- GOAC models demonstrated specific bacterial prosperity under phage pressure.
- Mucus-binding phages did not alter *E. coli* dynamics in GOAC, unlike in vivo models.
- Genomic modifications correlated with phage resistance in some cases, but alternative evasion strategies were observed.
Conclusions:
- GOAC models offer insights into gut bacterial-phage interactions.
- Phage therapy efficacy may depend on specific conditions and bacterial evasion mechanisms.
- Further research is needed to understand bacterial adaptation and develop effective phage treatments.

